Authors: STASCHKE KA RICHARDSON KK MABRY TE BAXTER AJ SCHEURING JC HUFFMAN DM SMITH WC RICHARDSON FC COLACINO JM

Citation: Ka. Staschke et al., DIFFERENTIAL-EFFECTS OF THE INCORPORATION OF OXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL (FIAU) ON THE BINDING OF THE TRANSCRIPTION FACTORS, AP-1 AND TFIID, TO THEIR COGNATE TARGET DNA-SEQUENCES, Nucleic acids research, 24(21), 1996, pp. 4111-4116

Authors: MABRY TE JONES CD CHOU TS COLACINO JM GRINDEY GB WORZALLA JF PEARCE HL

Citation: Te. Mabry et al., SYNTHESIS OF ETA-D-RIBOFURANOSYLAMINO)PYRIMIDO[5,4-D]PYRIMIDINE (DFARPP) - STABILITY AND CELLULAR CYTOTOXICITY, Nucleosides & nucleotides, 13(5), 1994, pp. 1125-1133

Authors: STASCHKE KA COLACINO JM MABRY TE JONES CD

Citation: Ka. Staschke et al., THE IN-VITRO ANTI-HEPATITIS-B VIRUS ACTIVITY OF FIAU 2'-FLUORO-1-BETA-D-ARABINOFURANOSYL-5-IODO)URACIL] IS SELECTIVE, REVERSIBLE, AND DETERMINED, AT LEAST IN PART, BY THE HOST-CELL, Antiviral research, 23(1), 1994, pp. 45-61

Authors: BOWSHER RR COMPTON JA KIRKWOOD JA PLACE GD JONES CD MABRY TE HYSLOP DL HATCHER BL DESANTE KA

Citation: Rr. Bowsher et al., SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR FIALURIDINE - INITIAL ASSESSMENT OF PHARMACOKINETICS AFTER SINGLE ORAL DOSES TO HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2134-2142